Apr 7 Cardiology News

Cost effects of risk-factor management in AF, apixaban costs vs warfarin, bioresorbable-scaffold woes, exercise as heart-failure therapy, and surgical left atrial appendage closure are discussed.

Source: Medscape Cardiology Podcast - April 7, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts